4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LBPS | LPCN | ENLV | ||
| Company | 4D Pharma Plc ADR | Lipocine Inc | Enlivex Therapeutics Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.6100 | 5.39 | 1.4700 | ||
| High | 1.6500 | 5.68 | 1.4800 | ||
| Low | 1.6100 | 5.13 | 1.3650 | ||
| Last | 1.6500 | 5.62 | 1.4200 | ||
| Change | +0.0400 | +0.27 | -0.0300 | ||
| % Change | +2.48% | +5.05% | -2.07% | ||
| Volume | 3,900 | 27,900 | 71,700 | ||
| 20-Day Average Volume | 16,215 | 30,330 | 96,240 | ||
| Previous Close | 1.6100 | 5.35 | 1.4500 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.6758 | 4.97 | 1.4965 | ||
| 20-Day Raw Stochastic | 7.81% | 95.31% | 31.14% | ||
| 20-Day Relative Strength | 27.94% | 59.43% | 34.69% | ||
| Weighted Alpha | -82.00 | +38.85 | -48.93 | ||
| Today's Opinion | 100% Sell | 100% Buy | 56% Sell | ||
| Previous Opinion | 100% Sell | 96% Buy | 56% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -29.78% since 06/16/22 | +15.88% since 05/08/24 | -8.39% since 05/08/24 | ||
| Low | 1.5000 on 06/22/22 | 4.90 on 05/09/24 | 1.3650 on 05/15/24 | ||
| High | 2.4600 on 06/17/22 | 5.68 on 05/15/24 | 1.5685 on 05/09/24 | ||
| 1-Month | |||||
| %Chg | -48.44% since 05/24/22 | +4.95% since 04/15/24 | +9.23% since 04/15/24 | ||
| Low | 1.5000 on 06/22/22 | 4.40 on 04/24/24 | 1.2301 on 04/19/24 | ||
| High | 3.4200 on 05/27/22 | 5.68 on 05/15/24 | 1.8400 on 04/29/24 | ||
| 3-Month | |||||
| %Chg | -69.56% since 03/24/22 | +40.15% since 02/15/24 | -55.76% since 02/15/24 | ||
| Low | 1.5000 on 06/22/22 | 3.20 on 03/07/24 | 1.1500 on 04/15/24 | ||
| High | 5.5000 on 03/25/22 | 7.15 on 04/11/24 | 4.5900 on 04/03/24 | ||
| 6-Month | |||||
| %Chg | -71.31% since 12/23/21 | +105.86% since 11/15/23 | -18.86% since 11/15/23 | ||
| Low | 1.5000 on 06/22/22 | 2.38 on 11/30/23 | 1.1500 on 04/15/24 | ||
| High | 8.8000 on 03/23/22 | 7.15 on 04/11/24 | 4.5900 on 04/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 27,114 | 28,611 | 26,969 | ||
| Shares Outstanding, K | 16,433 | 5,348 | 18,599 | ||
| Annual Sales | 720,000 | -2,850,000 | 0 | ||
| Annual Net Income | -31,940,000 | -16,350,000 | -29,070,000 | ||
| Last Quarter Sales | N/A | 7,620,000 | 0 | ||
| Last Quarter Net Income | N/A | 3,510,000 | -9,100,000 | ||
| 60-Month Beta | 0.71 | 1.11 | 1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.66 on 05/09/24 | -0.48 on 03/29/24 | ||
| Latest Earnings Date | 03/30/23 | 05/09/24 | 06/21/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||